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Introduction
Current State Of Fluoroscopy Use In Electrophysiology Labortory
As the first imaging modality of the living human body, X-ray 
fluoroscopic imaging has been the most important technical tool in 
modern medicine (Roentgen). It allowed one to see the inside of the 
body and, after contrast injection, even of soft tissues like the beat-
ing heart.1 To date, most of interventional procedures in cardiology 
are carried out under fluoroscopic imaging guidance. Besides other 
peri-interventional risks, radiation exposure should be considered 
for its stochastic (inducing malignancy) and deterministic effects on 
health (tissue reactions like erythema, hair loss and cataracts).2
Due to increased interventional procedures and imaging studies in 
the last decades, patients are being exposed to a substantial amount of 
radiation over their lifetime. Some procedures like catheter ablation 
of atrial fibrillation frequently requires cardiac computed tomogra-
phy (CT) scan before the intervention and more than one ablation 
procedure, thereby adding a substantial amount of radiation.3 On an 
average, a complex cardiac radiofrequency ablation corresponds to 
750 chest X-rays (range 100–2850).4 Recently, attention has been 
applied to the radiation exposure of the catheter lab staff who expose 
themselves professionally. Being close to the patient during an inter-
ventional procedure, the first hand operator is exposed to scattered 
radiation, whilst other health care professionals are better protected 
by their position at a greater distance to the radiation source and the 
patient itself.5 
Besides the associated X-ray exposure, the main limitation of fluor-
oscopy is that in complex arrhythmias fluoroscopy only provides 
two-dimensional (2D) representations of three dimensional (3D) an-
atomical structures as potentials targets for ablation. With the evolu-
tion of technology, new non fluoroscopic 3D mapping systems from 
the late 1990s have been an alternative to fluoroscopy alone in elec-
trophysiology world. Infact constructing a virtual real time 3D map, 
catheter navigation is facilitated while minimizing or eliminating 
fluoroscopy exposure. New software upgrades to non fluoroscopic 
3D mapping have resulted in very detailed cardiac chambers, poten-
tially eliminating pre-procedure CT imaging.
In this article we analized the radiation risk from cardiovascular 
imaging to both patients and medical staff and discusses how to cus-
tomize the X-ray system and how to implement shielding measures 
in the cath lab. Finally, we reviewed the most recent developments 
and the latest findings in catheter navigation and 3D electronatom-
ical mapping systems that may help to reduce patient and operator 
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per procedure. Despite a significant smaller radiation exposure for 
operators, recent reports have hinted an excess risk of brain tumors 
(predominantly at the more exposed left side) and (left sided) breast 
cancer in female cardiologist.19 Since the stochastic effects are cumu-
lative, a reduction in the use of fluoroscopy would be beneficial also in 
reducing the burden of cumulative effective dose of the cardiologist.
DNA Damage  Upon Ion Radiation: Detection In Patients And 
Hospital Workers
One of the major limits in assessing cancer risk in low radiation 
exposed patients consists in the need of a correct and precise measure 
of radiation-induced DNA damage. The most widely used assay to 
detect DNA damage is the micronucleus (MN) assay. Micronuclei 
are extra-nuclear bodies containing a portion of or a whole chromo-
some which was not carried to the opposite poles during cell division. 
Their formation results in the daughter cell lacking a part of or a 
whole chromosome. After cellular aberrant separation, micronuclei 
normally develop nuclear membranes and form as a third small nu-
cleus. Severe genetic damage can lead to the formation of more than 
one micronucleus.
MN assay has been used by Andreassi et al. in one of the first stud-
ies regarding DNA damage in patients undergoing cardiovascular 
procedures.20 In particular, the researchers performed chromosom-
al damage analysis in 72 patients undergoing invasive interventions 
such as: coronary angiography, percutaneous coronary intervention, 
transluminal angioplasty and cardiac resynchronization therapy. MN 
frequency evaluation after 2 and 24 hours post intervention showed 
a significant rise in DNA damage. In a similar study, MN assay was 
used to assess the entity of radiation induced genetic aberrations in 
18 out of 59 children with complex congenital diseases undergoing 
cardiac catheterization procedures. As in the previously cited study, 
Ait-Ali and coworkers showed a significant increase in MN forma-
tion as soon as 2h after procedures, a result clearly hinting to a great 
need for strict radiation dose optimization in particular in patients of 
young age and with a long life expectancy.21
Recently, additional markers to estimate radiation induced DNA 
damage have been proposed and investigated. In particular, γ-H2AX 
foci immunodetection have been described as a useful and quantita-
tive biomarker of low-level radiation exposure.22 This assay relies on 
the fact that ionizing radiation induces DNA double strand breaks 
(DSB) and, in turn, activates histone H2AX within 3 minutes af-
ter DNA damage, via phosphorylation of Ser 139;23 this particular 
phosphorylated form of H2AX tends to form foci and seems to be 
essential for the DNA damage repair, in addition to having been 
demonstrated to be directly proportional to damage extent (1 focus 
= 1 DNA DSB).24 This assay has been used in a recent work by Beels 
at al. to detect and quantitate DNA damage in pediatric patients 
undergoing cardiac catheterization; the investigators demonstrated 
a net increase in γ-H2AX foci after the procedures, again showing 
the importance of radiological awareness to minimize the possible 
long term oncogenic effects of x-ray exposure.25 Beside currently used 
assays, which are able to directly detect DNA damage induced upon 
irradiation, some new possible biomarkers are being currently pro-
posed to increase the reliability of risk assessment for both patients 
and hospital operators. Indeed, risk assessment based on DNA dam-
age in hospital workers exposed to ionizing radiation has been the 
subject of numerous studies in the past, and both MN and Comet 
assays have been employed.26,27,28,29 Comet Assay (the nickname for 
exposure.
Radiation Risk Associated With Radiofrequency Catheter 
Ablation Procedures 
How To Measure Radiation Exposure?
Fluoroscopy time and Dose Area Product (DAP) are widely used 
to assess the patient risk as reported by several studies, for they are 
rather easy to measure. Nevertheless the first is not even a dosimetric 
quantity, the latter, although somewhat useful to avoid skin injuries 
during prolonged procedures, does not take into account of specif-
ic factors such as the beam geometry with respect to the patient. 
Therefore none of them is adequate to estimate the patient risk. The 
International Commission on Radiological Protection recommends 
the use of the Effective Dose (ED), expressed as Sievert (Sv) or mil-
liSievert (mSv) and usually reported as a range, to estimate the radi-
ation detriment.6,7 Conversely only a small number of RFA studies 
have reported ED estimations. Table 1 reports the studies with 10 
or more patients published between 1994 and 2013 including ED 
estimations in their results.8,9,10,11,12,13,14,15 The average values per sin-
gle procedure felt in the range of 5.7–24.4 mSv, which correspond 
to lifetime attributable cancer risks of 0.02–0.1%. Such values are 
generally considered acceptable, although substantially higher com-
pared to the average ED values of other radiological procedures, and 
may exceed 50–100 mSv in some cases of complicated or repeated 
procedures.
The Committee on the Biological Effects of lonizing Radiation 
(BEIR) proposed a method to assess the risk of cancer incidence and 
mortality from patient dosimetry, dependent on age at exposure and 
gender.16 Figure 1 shows the estimates of life-time attributable risk 
(LAR) in function of the age at exposure for males and females esti-
mated from average effective doses calculated using the values from 
the reported literature (19 mSv). As expected, the risks decreased 
with age at exposure and were higher in females. The average cancer 
risk was 205 cases per 100000 procedures with 89 fatal malignancy 
for exposure-age of 40 years. The risks were almost doubled for expo-
sure-age of 15 years.
The EDs for medical staff are usually significantly smaller com-
pared to patient EDs, since the radiation exposure is lower. Several 
studies published between 1994 and 201314,17,18 reported ED estima-
tions for the medical personnel of RFA procedures. The ED values 
for the first operator were about 2 – 3 orders of magnitude smaller 
than patient EDs and average values varied between 1.8 and 65.6 μSv 
Figure 1:
Lifetime attributable risk of cancer incidence (solid line) and 
mortality (dash-dot line) induced by radiation exposure during RFA 
procedure with the 95% confidence interval confidence interval 
(dashed lines) in function of age at exposure for females (left) and 
males (right), for a mean effective dose of 19.1 mSv per procedure 
estimated from reported literature. 
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in the expression of 28 proteins. Interestingly, the same study evi-
denced radiation induced alterations in the levels of 2 microRNAs, 
miR-146b and -21, the latter being putatively able to target 3 out of 
the 28 radiation-modulated proteins (Desmoglein 1, phosphoglycer-
atemutase and target of Myb protein 1).
Transcriptional regulation in ex-vivo irradiated cells was the focus 
of investigation of Manning and colleagues in a recent study showing 
that both low and high doses of ionizing radiations can modulate the 
expression of specific genes. In particular, the researchers showed a 
dose response effect in the levels of 13 genes that were modulated 
after 2 and/or 24 h post cells irradiation. 
The possible limit of these new approaches consists in the lack of 
data on their possible application for long term cancer risk assess-
ment.
The Growing Culture of Radiation Protection 
Since Vaseline To 3D Technology
Within 12 months of the Röntgen"s discovery of X rays in 1895, 
papers appeared in the literature reporting adverse effects from high 
exposure. Just 1 year after, the American engineer Fuchs gave what 
is generally recognized as the first protection advice: a) make the 
exposure as short as possible, b) do not stand within 30 cm of the 
X-ray tube, and c) coat the skin with Vaseline and leave an extra 
layer on the most exposed area. Thus, within 1 year of dealing with 
radiation, the three basic tenets of practical radiological protection – 
time, distance, and shielding – had been established. Gradually, the 
need of radiation protection led to the foundation of a protection 
committee, established at the second International Congress of Ra-
diology in Stockholm in 1928. While initially, radiation protection 
aimed to avoid visible and early effects after prolonged exposure to 
radiation, subsequently the rules on radiation exposure were formu-
lated to prevent late harmful effects such as cancer induction. Indeed, 
most of the information available on the effects of radiation exposure 
in humans was based observing the survivors of the Hiroshima and 
Nagasaki bombings.
ALARA - As Low As Reasonably Achievable - is the safety 
principle designed to minimize radiation doses received by radia-
tion workers using practical, cost-effective measures. The ALARA 
assumption is that there is no measurable dose of radiation that can 
be considered safe. Radiation dose and its biological effects on living 
tissues are modeled by a relationship known as “linear-no-threshold” 
risk model. Every radiation dose of any magnitude can produce some 
level of detrimental effects that may include increased risk of genetic 
mutations and cancer.
With the interest in minimizing radiation dosage, a variety of al-
ternative approaches were investigated to provide guidance in the 
interventional cardiology laboratories. Three-dimensional non fluor-
oscopic mapping systems have revolutionized the “way-to-do” of EP 
operators.33,34,35,36 The most commonly used are the CARTO®system 
(Biosense Webster, Inc., Diamond Bar, CA, USA) and the EnS-
iteNavX system (St. Jude Medical, Inc., St. Paul, MN, USA) (Figures 
2-5). In addition, a new system, the Rhythmia™ mapping system 
(Rhythmia Medical, Burlington, MA, USA), has been recently de-
veloped and introduced in clinical practice. Briefly, the principle of 
catheter navigation with the CARTO® mapping system is magnet-
ic-field whilst the NavX technology works with impedance-based 
measurements (electrical field). These technologies allow to accu-
rately determine the location of arrhythmia origin, define cardiac 
single-cell gel electrophoresis) is a simple method for measuring de-
oxyribonucleic acid (DNA) strand breaks in eukaryotic cells. Cells 
embedded in agarose on a microscope slide are lysed with detergent 
and high salt to form nucleoids containing supercoiled loops of DNA 
linked to the nuclear matrix. Electrophoresis at high pH results in 
structures resembling comets, observed by fluorescence microscopy; 
the intensity of the comet tail relative to the head reflects the number 
of DNA breaks.
All these studies evidenced a long term effect on circulating cells of 
exposed hospital workers, with a possible role for smoke as additional 
risk factor.
In a recent work by Andreassi et al, a new approach consisting in 
the association of single nucleotide polymorphisms (SNPs) in DNA 
repair genes with MN assay demonstrated that genetic predisposi-
tion seems to increase chromosomal DNA damage levels in inter-
ventional cardiologists.30 Lately, new possible molecular markers of 
DNA damage in endothelial and blood cells have been discovered 
that could lead to the introduction of new sensitive and rapid assays 
to detect and quantify the negative effects of ionizing radiations.31,32 
In their study, Barjactarovic and coworkers investigated the effects of 
low-dose gamma radiation on the proteome of coronary artery en-
dothelial cells cultivated in vitro, showing a significant deregulation 
Figure 2:
Panel A: Catheters were placed from the right femoral vein and 
advanced up to inferior vena cava to the right atrium and confirmed 
by the presence of atrial electrograms. On the left RAO view; on the 
right LAO view. Panel B: typical, full right sided geometry as drawn 
by Ensite System. On the left RAO view; on the right LAO view. 
IVC: inferior vena cava; RA: right atrium; RV: right ventricle; RVOT: 
right ventricle outflow tract. AO: ascending aorta. 
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a transvenous ultrasound probe placed in the right heart, reducing 
fluoroscopy times and doses. These catheters have been extensively 
used in order to guide transseptal catheterization.42,43 Moreover, ICE 
helps to define the anatomy of the left atrium, pulmonary veins and 
visualize target structures during EP procedures.44,45 In addition, it is 
possible to visualize the lesion site and formation, such as swelling 
and crater formation and to promptly identify possible complications 
such as occurrence of microbubbles, clot formation and pericardial 
effusion.46 Real-time 3D transesophagel echocardiography (TEE) 
can be used as an alternative to ICE. However, post-acquisition im-
age processing is time-consuming and general anesthesia with en-
dotracheal intubation is required in all patients.47,48
Rotational Angiography
Recently, 3D rotational angiography (DynaCT, Siemens) has been 
introduced as an intraoperative modality for 3D imaging during car-
diac ablation. In 3D rotational angiography (3DRA), the C-arm typ-
ically performs a 200° rotation around the patient. A large number of 
2D projections are acquired over the course of the rotation. Recon-
struction algorithms construct these into 3D images by volume or 
surface rendering. With adequate contrast agent administration and 
cardiac motion reduction, the image quality delivered by 3DRA has 
been shown to be comparable to or even exceeding classical cardiac 
computerized tomography.49,50 This technique also reduces the eco-
nomic impact due to additional expensive imaging studies. Moreover, 
3DRA images are more likely to represent the true anatomy than a 
remotely acquired image, such as CT scan or MRI image, because of 
factors like the patient"s breathing and heart motion.51
Remote 3D Magnetic Navigation Systems and Robotic Catheter 
System
The use of remote navigation systems could systematically decrease 
clinician fatigue and fluoroscopy exposure. Currently there are two 
remote systems: the NiobeStereotaxis Magnetic Navigation System 
(Stereotaxis, Inc., St Louis, MO) and the Hansen Sensei Robot-
ic Catheter System (Hansen Medical, Mountain View, CA). Both 
systems allow the physician to perform the mapping and ablation 
procedure while sitting in a control room remote from the patient 
(Figure 7). 
The Niobe Stereotaxis Magnetic Navigation System (MNS) oper-
ates by using two large permanent magnets placed on either side of 
the patient that create a magnetic field inside the chest of the patient 
in which a catheter with magnetic tip, 7-F 3.5-mm-tip floppy irrigat-
ed catheter (Navistar RMT), can be moved in the desired directions, 
just modifying the magnetic field using a joystick in the control room, 
and used for mapping and ablation. In addition, the system includes a 
dedicated 3D EAM system (CARTO RMT). Significant disadvan-
tages of MNS are the extremely high cost of the system itself and the 
need of a dedicated EP laboratory properly shielded.52,53,54 Focusing 
on fluoroscopy times and radiation doses, different groups reached a 
significant reduction in fluoroscopy time and in radiation dose.55,56,57
The Hansen™ (Hansen Medical Inc., Mount View, CA) Robotic 
system is a flexible, robotic platform that combines 3D catheter con-
trol and visualization. The hand motions applied at the workstation 
are transferred to the catheter inside the heart of the patient. The 
major advantage is that once the catheter reaches the target site the 
robotic hand guarantees an extremely stable position. In addition, 
the IntelliSense™ technology provides the information about how 
much pressure is being exerted by the catheter. The Hansen system 
chamber geometry in 3D, delineate areas of anatomic interest, and 
allow catheter manipulation and positioning without fluoroscop-
ic guidance. Later versions of these mapping systems have allowed 
the fusion with MRI image or CT scan (Figure 4) and significant 
reduction in fluoroscopy exposure was demonstrated.37,38 Another 
extension to the CARTO mapping technology enabling ultrasound 
integration was the CARTOSound (Figure 4). It creates a 3D image 
of a specific heart chamber undergoing cardiac ablation by utiliz-
ing an intracardiac ultrasound catheter.39,40 The competition between 
these systems has led to a “mapping race”resulting in the systems 
developing increasingly similar characteristics including the ability 
to visualize multiple non-proprietary catheters.
A new sensor-based non fluoroscopic approach, developed by 
MediGuide and St Jude Medical, is recently entered in the market. 
Clinical application of the gMPS technology in electrophysiology 
revealed feasibility of non fluoroscopic catheter visualization with-
in the work flow of conventional invasive diagnostic EP procedures 
with significant reduction in X-ray exposure up to 80% especially for 
the treatment of complex arrhythmias.41
The innovative CARTOUnivu module provides for fixed fluoro-
scopic images or cines to be transferred to the 3-D electro-anatomic 
mapping system. The module allows real-time visualization of intra-
cardiac catheters against a background of a stored fluoroscopic image 
(Figure 2). Typically, multiple fluoroscopic images (three to eight) 
are acquired at different angulations and stored. Once transferred, 
the fluoro image is integrated into the 3-D map view, allowing the 
user to create an electroanatomical map on top of the captured fluor-
oscopic image or looping cine. Not only does this proved fluoroscop-
ic images for reference, electrophysiologists consistently commented 
that it diminished the interest in confirming catheter location with 
additional fluoroscopy. In a non-randomized retrospective study, re-
searchers found a statistically significant reduction in fluoroscopy 
times and in dosages for EP ablation procedures utilizing the CAR-
TOUnivu module fluoroscopic integration system.
Echocardiography
Intracardiac echocardiography (ICE) allows to obtain detailed im-
aging of cardiac structures from within the vascular system, using 
Figure 3:
Left atrium (gray), inferior vena cava (green) and CS anatomy (blue) 
as drawn with CARTO System. On the left PA view; on the right LAO 
view. 
IVC: inferior vena cava; CS: coronary sinus; LA: left atrium; TP: 
transeptal puncture. 
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dose to less than 20 mSv/y, averaged over a 5-year period, according 
to current recommendations of International Commission on Radi-
ation Protection.66
The RADPAD (Worldwide Innovations & Technologies, Inc., 
Kansas City, KS) is a Bismuth-made, disposable, sterile, lead-free 
surgical drape. Being positioned on the patient, it has been shown 
to reduce scatter radiation, in particular during complex device im-
plantation.67,68
The radiation protection units have been developed to reduce the 
development of long-term orthopedics problems such as aches and 
pains in the neck, back, hips, knees and ankles that ranges in sever-
ity.69,70 Cathpax (LemerPax, Carquefou, France), a radiation protec-
tion cabin, was developed as alternative protection apparel.71 It uses 2 
mm lead-equivalent walls, including transparent leaded plastic in its 
upper parts, to surround the operator on two sides and from above. 
This unit is mobile, adjustable in height, and is prepared with specif-
ically designed drapes to provide sterile patient access. ZeroGravity 
(Zgrav, CFI Medical Solutions) is an entirely suspended radiation 
protection system. It is made of a suspended lead apron covering the 
operator from head to calf excluding right arm and left forearm.72 
Recently, Fattal and Goldstein described the first in man clinical use 
of a complete barrier radiation unit - Trinity System (ECLS, Salt 
Lake City, UT).73
Use Of Non-Fluoroscopic Guiding Technology In Order To 
Obtain A Minimally Fluoroscopic Approach
In the last few years several papers and case-reports have been pub-
lished showing the feasibility and safety of a totally non fluoroscopic 
approach using mapping system principally as navigation system in 
order to move the catheters through the vessels and the heart cham-
bers.
Below the main studies that have used a minimally fluoroscopic 
approach thanks to the navigation/mapping systems in different set-
ting of patients.
Pediatric Population
While minimizing fluoroscopy is prudent for everyone, children 
are at an increased risk from radiation exposure because they are 
growing and have a longer life expectancy.74 Children receive also 
a greater effective dose as scatter radiation has a shorter distance to 
travel to reach sensitive organ such as the bone marrow, liver and 
breast tissue.75 For these reasons children are more susceptible to the 
risk of radiation-induced carcinogenesis and decreasing fluoroscopic 
exposure during electrophysiologic ablation procedures gives them a 
greater benefit compared with adults.76 Among the pediatric popula-
tion, children with congenital heart disease are at an even higher risk. 
Owing to anatomic alterations and multiple substrates, procedures 
are often longer than in patients with structurally normal hearts and 
they are likely to have multiple procedures.
With increasing operator experience, fluoroscopy times decreased 
from nearly an hour in 1991-1992, to 40 min in 1995-1996 and to 
36 min in 2004.77,78,79
Ablation of supraventricular tachycardia is the most common 
procedure performed in children and first experiences in reducing 
fluoroscopy exposure were performed in this subset. Drago et al. in 
2002 described for the first time the feasibility and efficacy of min-
imal-fluoroscopy ablation of right-sided accessory pathways using 
the CARTO three-dimensional navigation system in children with 
normal heart anatomy.80 Starting from this first experience, in the 
does not require a dedicated 3D EAM system, but is equally com-
patible with CARTO and NavX systems.52 Since the preliminary 
human experience published in 2008, the robotic navigation system 
has been shown to be safe and feasible, with similar results compared 
with the manual approach, and to significantly reduce radiation ex-
posure.53,54,58,59
Radiation Protection Tools
Despite the wide use of 3D EAM, ultrasound-guided procedures 
and remote catheter navigation, X-ray technology is still the most 
commonly utilized technique for medical imaging. The greatest 
source of X rays to the operator and staff is scatter from the patient. 
Chronic radiation exposure in the work place requires the use of pro-
tective tools in order to limit occupational radiation dose to an ac-
ceptable level. The purpose of radiation protection tools is to improve 
operator and staff safety without impeding the procedure or jeopard-
izing the patient"s safety. There are different tools currently available 
for radiation protection in the electrophysiology laboratories: archi-
tectural shielding, equipment-mounted shields, personal protective 
devices, personal mobile shields and radiation protection units.60,61
Architectural shielding is built into the walls of the EP laboratory. 
In addition, rolling and stationary shields, constructed of transparent 
leaded plastic, are available and are useful for providing additional 
shielding for both operators and staff.62
Equipment-mounted shielding includes tables-suspended and 
ceiling-suspended shields. It has been shown to substantially reduce 
the operator"s dose. Table-suspended shielding are drapes positioned 
between the X-ray tube and the operator from the side of the pa-
tient table. Unfortunately, they are ineffective when the C-arm is in 
oblique or lateral position. Ceiling-suspended shielding are leaded 
plastic shields positioned between the operator face and the X-ray 
detector.63,64
Personal protective devices include aprons, thyroid shields, eye-
wear, and gloves. Protective aprons with thyroid shields are the prin-
cipal radiation protection tools for interventional workers. More ad-
vanced equipment also includes lead caps. According to regulations, 
it is necessary the use of apron of at least 0.5 mm lead equivalent 
thickness. Transmission of 70-100kVp X-rays through 0.5 mm lead 
ranges from 0.5 to 5%.65 Effective personal protective devices use is 
expected from every staff member in order to maintain the radiation 
Figure 4:
Screen shot of the CARTO system. On the left, intracardiac 
echocardiography (ICE) 2D image of the left atrium (LA), left 
superior and left inferior pulmonary veins. The green lines represent 
the endocardial borders. On the right, co-registration of the LA ICE 
3D anatomical shell and preoperative cardiac CT scan 
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ping (study group). The success rate was 97% in the control group 
and 100% in the study group without differences in adverse events. 
Non-fluoroscopic imaging reduced median fluoroscopy time by 59% 
(18.3 minutes vs 7.5 minutes, P<0.001) and radiation exposure by 
72% (387 vs 110 mGy, P<0.001).88 A second prospective, controlled, 
single-center study was published in 2013 and randomized to in-
tra-cardiac echocardiography plus electroanatomic mapping or elec-
troanatomic mapping only in children with normal cardiac anatomy 
performing ablation for supraventricular tachycardia. The use of in-
tra-cardiac echocardiography reduced the fluoroscopic exposure for 
transseptal puncture .
As a consequence of growing experience with non-fluoroscopic 
navigation systems, also accessory pathways in close proximity to 
the normal conduction tissue and arrhythmia other than supraven-
tricular tachycardia have been successfully ablated with minimal- or 
no-fluoroscopy.89 In 2011 it was described a small series of children 
that underwent ablation of ventricular arrhythmia  using electroan-
atomic mapping with 3D EnSiteNavX system. No fluoroscopy was 
used in patients with right-sided arrhythmia, while the two patients 
with left-sided arrhythmia had 1.0 and 1.9 minutes of fluoroscopy. 
Small amounts of radiation may be required for evaluation of coro-
nary arteries or other anatomic substrates.90 Last year the utility and 
safety of the NavX system in reducing fluoroscopy exposure during 
ablation of ventricular tachycardia was confirmed in a larger series of 
children.
There is a growing body of literature that demonstrates safety and 
efficacy of minimal or no-fluoroscopic use in pediatric patients un-
dergoing ablation procedures by using electroanatomic mapping sys-
tems. In most studies, this has been accomplished without extending 
procedure times. However, the use of electroanatomic mapping sys-
tems increases the cost of the procedures over fluoroscopy alone and 
requires a great experience.91 The extent to which long-term benefits 
outweigh the increased costs remains actually unknown. The publica-
tion of the NO-PARTY trial, the only one multi-centre, randomized 
controlled trial up to now, will probably give an answer to the cost-ef-
fectiveness of non-fluoroscopic radiofrequency catheter ablation, in 
addition to confirmation of the reduction of radiation exposure to 
the patient and to the operator and feasibility and safety of these 
procedures.
Adult Population
In contrast with the pediatric population, the greater number 
of procedures performed in the adult population allowed prospec-
tive-randomized trial to have been published since 2000. Kottkamp 
et al. where the first ones that randomized 50 patients with typical 
atrial flutter to receive isthmus ablation using conventional fluor-
oscopy for catheter navigation (group I, n=24) or electromagnetic 
mapping (group II, n=26). They demonstrated that electromagnet-
ic mapping permitted a high significantly reduction in exposure to 
fluoroscopy (22.0 ± 6.3 min in group I and 3.9 ± 1.5 min in group II; 
P<0,0001) reducing the exposure to levels anticipated for diagnostic 
electrophysiologic studies. The efficacy was maintained high in both 
groups . In 2003 Schneider et al. confirmed these findings in a series 
of 50 patients randomly assigned to undergo radiofrequency ablation 
of typical atrial flutter guided by a conventional fluoroscopy-based 
approach or by the LocaLisa system.92 The efficacy and safety of elec-
troanatomic mapping for the reduction of radiation exposure during 
ablation of typical atrial flutter was than reaffirmed in a larger series 
of patients in 2009 by Hindricks et al.93 They randomized a total of 
following years others studies have been published, investigating the 
feasibility of a minimal-fluoroscopic approach in almost all kinds of 
electrophysiologic procedures in children. In 2006 Papagiannis et al. 
described their experience with NavX for the ablation of atrio-ven-
tricular re-entrant tachycardia and both right and left-sided accessory 
pathways. They included also children with congenital heart disease, 
showing no significant differences in success rate.81 In 2007 Papez 
et al. and Smith et al. confirmed the feasibility and efficacy of the 
ablation of atrioventricular re-entrant tachycardia and atrioventricu-
lar nodal re-entrant tachycardia with LocaLisa and NavX system, 
respectively.82,83 Smith et al. used no fluoroscopy in 80% of the proce-
dures and pointed out that the most common reason for fluoroscopy 
use was the need to perform a transseptal puncture. In 2007 it was 
also described for the first time a case series of right-sided catheter 
ablation with cryo-energy and minimal-fluoroscopy.84 It was in 2008 
when the first series of transseptal puncture have been performed 
without fluoroscopy, thanks to the combination of trans-esophageal 
echocardiography and NavX guidance.85
Intracardiac echocardiography was introduced as a tool to reduce 
fluoroscopy exposure in 2010 when Kean et al. reported their expe-
rience with CARTOSound in treating different kinds of arrhyth-
mia. They included also children with congenital heart disease.86 The 
sub-population of children with congenital heart disease has been 
better investigated in 2011 by Papagiannis et al. They compared two 
groups of patients, one group undergoing fluoroscopic only ablation 
and the other one using NavX non-fluoroscopic navigation system. 
They performed a sub-analysis of children with congenital heart dis-
ease and observed that the reduction in fluoroscopic exposure with 
the use of the NavX system was preserved in this population.87
If previous described studies are retrospective studies, it was Mi-
yake et al. in 2011 that performed the first prospective, controlled, 
single-centre study of ablation of supraventricular tachycardia among 
children, randomizing to fluoroscopy (control group) or fluoroscopy 
+ AcuNav intracardiac ultrasound + NavX electroanatomic map-
Figure 5:
On the left: Inferior vena cava, right atrium and right ventricle 
outflow tract geometry as drawn with Ensite System. AP view. On 
the right: typical: right ventricle outflow tract (green) geometry as 
drawn by Ensite System. LAO view. White dots represent ablation 
point during of catheter ablation of frequent premature ventricular 
complexes arising from right ventricle outflow tract. 
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In the adult population, thanks to the wide use of a minimal- or 
no-fluoroscopic approach in the last years, it has been possible also 
a comparison between different non-fluoroscopic navigation systems 
in term of reduction of radiation exposure. In 2006 Earley et al. ran-
domized a total of 145 patients to a procedure guided by CARTO, 
Ensite NavX, or conventional mapping. Arrhythmias treated were 
typical atrial flutter, atrioventricular nodal re-entrant tachycardia and 
atrio-ventricular re-entrant tachiycardia. Overall procedure time, 
immediate and short-term success, complication rate, and freedom 
from symptoms at follow-up were identical for all groups. NavX led 
to the least X-ray exposure (NavX vs conventional, median: 4 vs 13 
min; NavX vs CARTO, median: 4 vs 6 min), especially when NavX 
was used for atrio-ventricular nodal re-entrant tachycardia or typical 
atrial flutter.101 A comparison between CARTO-Merge and CAR-
TO-XP was performed in 2010 in a randomized study in patients 
undergoing catheter ablation for paroxysmal and persistent atrial fi-
brillation. Image integration using CARTO-Merge shortened the 
X-ray exposure (28.8 ± 14.3 min vs 58 ± 8.7 min), though not im-
proving significantly the clinical outcome.102 Finally, in 2012 CAR-
TO 3 was compared with CARTO-XP in an observational study in 
patients treated for drug refractory atrial fibrillation. The use of the 
CARTO 3 system allowed a significant reduction in fluoroscopic ex-
posure (15.9 ± 12.3 min vs 26 ± 15.1 min; P<0.001).103
Pregnant Women
An increased incidence of maternal cardiac arrhythmia is observed 
during pregnancy both in women with normal cardiac anatomy and 
women with structural heart disease. In most cases no treatment is 
necessary but occasionally arrhythmia becomes a significant clini-
cal problem. Sustained arrhythmia can result in impaired blood flow 
to the fetus and fetal and neonatal adverse events are described in 
the literature, such as prematurity, respiratory distress syndrome, and 
small fetus for gestational age.104
Though anti-arrhythmic drugs should be the first line therapy, both 
the ACC/AHA and the ESC guidelines consider radiofrequency ab-
lation as a treatment option in case of drug-refractory and poorly 
tolerated tachycardia (IIbC).105,106 Due to high radiation exposure, 
ablation should be postponed to the second trimester if possible, and 
it should be performed at an experience ablation centre with suitable 
lead shielding and maximal use of echo- and electro-anatomic map-
ping systems.
210 patients with documented typical atrial flutter to conventional 
ablation strategy or electroanatomically guided mapping and abla-
tion (CARTO). The success was not significantly different between 
the two groups, but the fluoroscopy exposure time was reduced by 
almost 50% in the electroanatomically guided ablation group (7.7 ± 
7.3 min vs 14.8 ± 11.9 min; P<0,05). Of course, the cost of the pro-
cedures was higher in the study group (USD 3,870 vs USD 2,720).
In 2005 it was published the first randomized trial of reduction of 
fluoroscopic exposure in atrial fibrillation ablations. Seventy-two pa-
tients were randomized to ablation with or without non-fluoroscopic 
navigation. The target of pulmonary vein isolation was achieved in all 
patients and fluoroscopy was significantly reduced in the study group 
(15.4 ± 3.4 min vs 21.3 ± 6.4 min; P<0,001), demonstrating for the 
first time the feasibility and efficacy of minimal-fluoroscopic ablation 
for atrial fibrillation.94
Two prospective-controlled trials add themselves to the evidence 
of the feasibility of reduction of radiation exposure in the electro-
physiologic field, one in paroxysmal or permanent atrial fibrillation 
and the other one in atrioventricular nodal re-entrant tachycardia.95,96
Besides these prospective-randomized and prospective-controlled 
trials that demonstrate the feasibility and efficacy of a minimal-fluor-
oscopic approach, some observational studies have been published 
showing the chance to perform ablations completely without fluor-
oscopy. In 2009 Ferguson et al. published a series of 21 patients that 
underwent ablation for atrial fibrillation. In 19 of them no fluor-
oscopy was used thanks to the use of intra-cardiac echocardiogra-
phy and electroanatomic mapping navigation also for the transseptal 
puncture.97 The utility of the combination of intra-cardiac echocardi-
ography and electroanatomic mapping was then confirmed in 2010 
by Reddy et al. They evaluated this combination in 20 patients un-
dergoing pulmonary vein isolation for paroxysmal atrial fibrillation 
and observed that a completely fluoroless catheter ablation is safely 
feasible.98 Once it has been demonstrated that also the transseptal 
puncture could be performed safely without fluoroscopy, it is almost 
obvious that ablation of common atrial flutter, atrioventricular nodal 
re-entrant tachycardia and accessory pathways could be free from ra-
diation exposure too.99,100
Figure 6:
The robotic Sensei X system (Hansen Medical,CA) screen shot. 
On the left, left atrium as drawn with CARTO System. Upper right, 
fluoroscopy view. Bottom right, intracardiac echocardiography. 
Table 1: Mean effective doses in RFA procedures reported in previous studies
Study N patients Effective dose (mSy)
Wielandts et al.(2010)a 42 6.59
Perisinakis et al. 
(2001)b
24 5.67
Efstathopoulos et al. 
(2006)b
24 15.2
McFadden et al. (2002)b 50 17.0
Broadhead et al. (1997)b 81 17.3
Rosenthal et al. (1998)b 859 21.3
Lickfett et al. (2004)b 15 24.4
Macle et al. (2003)b,c 43 1.11
aEd calculated using tissue weighting factors from ICRP 103.
bED calculated using tissue weighting factors from ICRP 60.
cED values reported by Macle et al. are based on measurements from a single electronic 
dosimeter which was likely not positioned consisently in the X-ray beam, thus ED are probably 
underestimated.
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Supraventricular tachycardia is the most common sustained ar-
rhythmia during pregnancy.107 The incidence of supraventricular tach-
ycardia complicating pregnancy has been estimated to be between 13 
and 24 in 100000.108 Atrioventricular nodal re-entrant tachycardia 
and atrioventricular reciprocating tachycardia are the more common 
forms, but incessant focal atrial tachycardia is particularly challeng-
ing as anti-arrhythmic drugs are relatively ineffective.
Experience in pregnant women derives exclusively from case re-
ports or case series, involving women at any gestational age. All of 
them showed that ablation of supraventricular tachycardia with min-
imal- or no-fluoroscopic use is feasible and safe. No complication for 
the fetus was observed in any study.109,110
Besides supraventricular tachycardia, during pregnancy it has been 
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lol, sotalol and intravenous amiodarone for prevention of recurrent 
ventricular tachycardia in pregnancy, but radiofrequency ablation 
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10 Gycm2). Three months after ablation, a healthy girl was delivered 
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rarely been performed during pregnancy because any X-ray expo-
sure can be potentially harmful to the fetus. However, there are some 
cases in which radiofrequency ablation is the last resort solution and 
should be performed without hesitation to preserve two lives, the 
mother and the fetus one. Anyway, new non-fluoroscopic naviga-
tion systems allow performing ablation procedures with a very small 
amount of radiation or even without any radiation use. Considering 
that significant fetal complications are known to occur when expo-
sure rates exceed 50 Sv,115 the low-level radiation exposure showed in 
literature gives the chance to safely perform ablation procedures also 
in pregnant women affected by incessant arrhythmia and in a gesta-
tional age when delivery is not possible.116 In future cases, it could be 
useful to place dosimeters on the maternal fundus under the shield to 
better estimate fetal exposure.117
Conclusion:
An underappreciated silent complication of catheter ablation pro-
cedures is radiation exposure. X-Ray exposure results in acute com-
plications related to dose and time dependent exposure as well as a 
cumulative, lifetime risk to not only the patient but also the oper-
ator and electrophysiology staff. On an average, a complex cardiac 
radiofrequency ablation corresponds to 750 chest X-rays (range 100–
2850). A reduction of the occupational and the procedural doses by a 
factor of 10 to even 100 can be achieved simply by a radioprotection 
training programme. There are many avenues to reduce the radiation 
exposure through system and workflow adaptations and through the 
use of non-fluoroscopic imaging techniques. It is hoped to witness 
a new era of treating arrhythmias with a minimally fluoroscopic ap-
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